dc.contributor.author |
Terekhov S. |
|
dc.contributor.author |
Palikov V. |
|
dc.contributor.author |
Palikova Y. |
|
dc.contributor.author |
Dyachenko I. |
|
dc.contributor.author |
Shamborant O. |
|
dc.contributor.author |
Smirnov I. |
|
dc.contributor.author |
Masson P. |
|
dc.contributor.author |
Gabibov A. |
|
dc.date.accessioned |
2018-04-05T07:08:52Z |
|
dc.date.available |
2018-04-05T07:08:52Z |
|
dc.date.issued |
2017 |
|
dc.identifier.issn |
0007-4888 |
|
dc.identifier.uri |
http://dspace.kpfu.ru/xmlui/handle/net/129380 |
|
dc.description.abstract |
© 2017, Springer Science+Business Media, LLC. We present a procedure for optimizing the expression of recombinant tetrameric butyrylcholinesterase that enables large-scale production with the yield > 30 mg/liter ( > 90 mg/roller bottle). Intravenous injection of the preparation significantly increased survival and decreased the severity of symptoms of poisoning with paraoxon, an organophosphorus toxin. |
|
dc.relation.ispartofseries |
Bulletin of Experimental Biology and Medicine |
|
dc.subject |
biological drug |
|
dc.subject |
organophosphate toxins |
|
dc.subject |
paraoxon |
|
dc.subject |
prevention of poisoning |
|
dc.subject |
tetrameric recombinant human butyrylcholinesterase |
|
dc.title |
Application of Tetrameric Recombinant Human Butyrylcholinesterase as a Biopharmaceutical for Amelioration of Symptoms of Acute Organophosphate Poisoning |
|
dc.type |
Article |
|
dc.relation.ispartofseries-issue |
4 |
|
dc.relation.ispartofseries-volume |
163 |
|
dc.collection |
Публикации сотрудников КФУ |
|
dc.relation.startpage |
430 |
|
dc.source.id |
SCOPUS00074888-2017-163-4-SID85028765096 |
|